RenovoRx Operating Income

RenovoRx (RNXT) currently reports a operating income of $-13M as of March 2026. That compares with $-12M in the prior-year period — down 10.9% year over year. Use the charts on this page to explore RenovoRx's operating income history and peer comparisons.

RenovoRx's operating income decreased from $-12M to $-13M — a 10.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RenovoRx reported $-13M in operating income as of March 2026. That compares with $-12M in the prior-year period — down 10.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RenovoRx, and consider following RNXT for alerts when major investors trade the stock.